Digital Mental Health Technology: Device Characterisation, Regulatory Qualification and Classification
UK regulator guidance setting out how digital mental health technologies (DMHTs), including AI chatbots, are characterised and when they qualify as software as a medical device and in which risk class. It defines two determining characteristics, intended purpose and functionality, distinguishes low-functionality computational tasks from high-functionality ones such as processing data with AI, and works through 29 worked functions with qualification examples mapped to UK MDR and EU MDR classification rules. Produced under the MHRA's Digital Mental Health Technology: Regulation and Evaluation for Safe and Effective Products programme.
Publisher
Medicines and Healthcare products Regulatory Agency (MHRA)
Published
3 Feb 2025
Added
today
DOI
—
Key Findings
- Qualification turns on two characteristics: the manufacturer's intended purpose (wellbeing support versus aiding treatment of a mental health condition) and functionality (how the product works).
- 'AI chatbot' is listed alongside e-coach, questionnaires, triage and personalised content as a DMHT function; a function that processes data using AI is classed as high functionality, which bears on whether the product qualifies as a medical device.
- Worked example: user sign-in through a generative-AI chatbot that responds to the user's input 'with the aim of creating a welcoming and compassionate environment' is rated high functionality even though its stated purpose is data collection.
- The guidance enumerates 29 DMHT functions, from fixed-content psychoeducation to just-in-time adaptive interventions, digital games and VR/AR, each with qualification reasoning.
- Version history: v1.1 (2025-02-13) reworded two examples; v1.2 (2025-07-03) added stakeholder-engagement detail, guidance on when a DMHT does not qualify as SaMD, and EU MDCG 2019-11 Rev 1 alignment; v1.3 (2026-07-29) changed the wording of function 11.
Methodology Notes
Regulatory guidance, not an empirical study. 54-page PDF (version 1.3, 886,831 bytes) published under the Open Government Licence at gov.uk; first published 2025-02-03, current version 2026-07-29. Developed with stakeholder engagement described in section 2. The document addresses qualification and classification only; clinical evaluation and evidence standards are covered by sibling MHRA/NICE outputs of the same programme. Companion gov.uk documents from the programme, 'Digital mental health technology: user and public perspectives on identifying and reporting harms' (2025-11-20) and 'Report on adverse event reporting in DMHTs' (2025-08-01), are not covered by this entry.
Sources
gov.uk publication page (MHRA)(opens in a new tab) (primary)
Guidance PDF, version 1.3 (54 pages)(opens in a new tab) (29 Jul 2026)
Archived snapshot (Wayback Machine)(opens in a new tab) — preserved against link rot
Tags
Cite This
APA
Medicines and Healthcare products Regulatory Agency (MHRA). (2025). Digital Mental Health Technology: Device Characterisation, Regulatory Qualification and Classification. https://www.gov.uk/government/publications/digital-mental-health-technology-qualification-and-classification